354 related articles for article (PubMed ID: 29655588)
1. Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model.
Lee M; Kim SH; Kim TG; Park J; Lee JW; Lee MG
J Dermatol Sci; 2018 Jul; 91(1):52-59. PubMed ID: 29655588
[TBL] [Abstract][Full Text] [Related]
2. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
3. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
[TBL] [Abstract][Full Text] [Related]
4. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice.
Wohn C; Ober-Blöbaum JL; Haak S; Pantelyushin S; Cheong C; Zahner SP; Onderwater S; Kant M; Weighardt H; Holzmann B; Reizis B; Becher B; Prens EP; Clausen BE
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10723-8. PubMed ID: 23754427
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
6. Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production.
Nakajima K; Kataoka S; Sato K; Takaishi M; Yamamoto M; Nakajima H; Sano S
J Dermatol Sci; 2019 Feb; 93(2):82-91. PubMed ID: 30514663
[TBL] [Abstract][Full Text] [Related]
7. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis.
Yoshida K; Kubo A; Fujita H; Yokouchi M; Ishii K; Kawasaki H; Nomura T; Shimizu H; Kouyama K; Ebihara T; Nagao K; Amagai M
J Allergy Clin Immunol; 2014 Oct; 134(4):856-64. PubMed ID: 25282566
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
9. Celastrol gel ameliorates imiquimod-induced psoriasis-like dermatitis in mice by targeting Langerhans cells.
Liu L; Chen X; Lu Y; Sun XY; Ze K; Zhou YQ; Li W; Li X; Li HJ; Li B
Biomed Pharmacother; 2022 Mar; 147():112644. PubMed ID: 35051865
[TBL] [Abstract][Full Text] [Related]
10. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
12. Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis.
Terhorst D; Chelbi R; Wohn C; Malosse C; Tamoutounour S; Jorquera A; Bajenoff M; Dalod M; Malissen B; Henri S
J Immunol; 2015 Nov; 195(10):4953-61. PubMed ID: 26466959
[TBL] [Abstract][Full Text] [Related]
13. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
14. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
17. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
18. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
[TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
20. Specific roles for dendritic cell subsets during initiation and progression of psoriasis.
Glitzner E; Korosec A; Brunner PM; Drobits B; Amberg N; Schonthaler HB; Kopp T; Wagner EF; Stingl G; Holcmann M; Sibilia M
EMBO Mol Med; 2014 Oct; 6(10):1312-27. PubMed ID: 25216727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]